Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and C...
Q2 2026
Jul 29, 2026
Q1 2026
May 4, 2026
FY 2025
Mar 10, 2026
Q4 2025
Q3 2025
Nov 12, 2025